CpG island hypermethylation-associated silencing of small nucleolar RNAs in human cancer

Much effort in cancer research has focused on the tiny part of our genome that codes for mRNA. However, it has recently been recognized that microRNAs also contribute decisively to tumorigenesis. Studies have also shown that epigenetic silencing by CpG island hypermethylation of microRNAs with tumor suppressor activities is a common feature of human cancer. The importance of other classes of non-coding RNAs, such as long intergenic ncRNAs (lincRNAs) and transcribed ultraconserved regions (T-UCRs) as altered elements in neoplasia, is also gaining recognition. Thus, we wondered whether there were other ncRNAs undergoing CpG island hypermethylation-associated inactivation in cancer cells. We focused on the small nucleolar RNAs (snoRNAs), a subset of ncRNA with a wide variety of cellular functions, such as chemical modification of RNA, pre-RNA processing and control of alternative splicing. By data mining snoRNA databases and the scientific literature, we selected 49 snoRNAs that had a CpG island within ≤ 2 Kb or that were processed from a host gene with a 5′-CpG island. Bisulfite genomic sequencing of multiple clones in normal colon mucosa and the colorectal cancer cell line HCT-116 showed that 46 snoRNAs were equally methylated in the two samples: completely unmethylated (n = 26) or fully methylated (n = 20). Most interestingly, the host gene-associated 5′-CpG islands of the snoRNAs SNORD123, U70C and ACA59B were hypermethylated in the cancer cells but not in the corresponding normal tissue. CpG island hypermethylation was associated with the transcriptional silencing of the respective snoRNAs. Results of a DNA methylation microarray platform in a comprehensive collection of normal tissues, cancer cell lines and primary malignancies demonstrated that the observed hypermethylation of snoRNAs was a common feature of various tumor types, particularly in leukemias. Overall, our findings indicate the existence of a new subclass of ncRNAs, snoRNAs, that are targeted by epigenetic inactivation in human cancer.

[1]  S. Hammond.  MicroRNAs as tumor suppressors , 2007, Nature Genetics.

[2]  Gabriele Varani,et al.  The structure and function of small nucleolar ribonucleoproteins , 2007, Nucleic acids research.

[3]  E. Bertrand,et al.  Human Box H/ACA Pseudouridylation Guide RNA Machinery , 2004, Molecular and Cellular Biology.

[4]  C. Croce,et al.  MicroRNA signatures in human cancers , 2006, Nature Reviews Cancer.

[5]  M. Esteller,et al.  Cancer epigenetics reaches mainstream oncology , 2011, Nature Medicine.

[6]  Lin He,et al.  MicroRNAs: small RNAs with a big role in gene regulation , 2004, Nature Reviews Genetics.

[7]  Tsung-Cheng Chang,et al.  Widespread microRNA repression by Myc contributes to tumorigenesis , 2008, Nature Genetics.

[8]  David Haussler,et al.  Human Genome Ultraconserved Elements Are Ultraselected , 2007, Science.

[9]  Tom H. Pringle,et al.  The human genome browser at UCSC. , 2002, Genome research.

[10]  Wei Zhou,et al.  Implication of snoRNA U50 in human breast cancer. , 2009, Journal of genetics and genomics = Yi chuan xue bao.

[11]  M. Esteller.  Non-coding RNAs in human disease , 2011, Nature Reviews Genetics.

[12]  Weixiong Zhang,et al.  Characterization and Identification of MicroRNA Core Promoters in Four Model Species , 2007, PLoS Comput. Biol..

[13]  Michel J. Weber,et al.  Mammalian Small Nucleolar RNAs Are Mobile Genetic Elements , 2006, PLoS genetics.

[14]  Carla Oliveira,et al.  A TARBP2 mutation in human cancer impairs microRNA processing and DICER1 function , 2009, Nature Genetics.

[15]  J. Steitz,et al.  A mammalian gene with introns instead of exons generating stable RNA products , 1996, Nature.

[16]  F. Slack,et al.  Oncomirs — microRNAs with a role in cancer , 2006, Nature Reviews Cancer.

[17]  Joel S Parker,et al.  Extensive post-transcriptional regulation of microRNAs and its implications for cancer. , 2006, Genes & development.

[18]  Yuping Li,et al.  Genome-wide analyses of retrogenes derived from the human box H/ACA snoRNAs , 2006, Nucleic acids research.

[19]  W. Filipowicz,et al.  Exonucleolytic processing of small nucleolar RNAs from pre-mRNA introns. , 1995, Genes & development.

[20]  Tamás Kiss,et al.  Site-Specific Pseudouridine Formation in Preribosomal RNA Is Guided by Small Nucleolar RNAs , 1997, Cell.

[21]  S. Stamm,et al.  The snoRNA HBII-52 Regulates Alternative Splicing of the Serotonin Receptor 2C , 2006, Science.

[22]  J. Bachellerie,et al.  Targeted ribose methylation of RNA in vivo directed by tailored antisense RNA guides , 1996, Nature.

[23]  J. Bonfield,et al.  Finishing the euchromatic sequence of the human genome , 2004, Nature.

[24]  Anthony M. Poole,et al.  Evolutionarily Stable Association of Intronic snoRNAs and microRNAs with Their Host Genes , 2009, Genome biology and evolution.

[25]  Anton J. Enright,et al.  Genomic analysis of human microRNA transcripts , 2007, Proceedings of the National Academy of Sciences.

[26]  C. Koh,et al.  Overexpression of ribosomal RNA in prostate cancer is common but not linked to rDNA promoter hypomethylation , 2011, Oncogene.

[27]  A. Hüttenhofer,et al.  The expanding snoRNA world. , 2002, Biochimie.

[28]  Long-Sen Chang,et al.  Differential expression of human 5S snoRNA genes. , 2002, Biochemical and biophysical research communications.

[29]  M. Mourtada-Maarabouni,et al.  GAS5, a non-protein-coding RNA, controls apoptosis and is downregulated in breast cancer , 2009, Oncogene.

[30]  T. Vulliamy,et al.  Genetic heterogeneity in autosomal recessive dyskeratosis congenita with one subtype due to mutations in the telomerase-associated protein NOP10. , 2007, Human molecular genetics.

[31]  B. Rogelj,et al.  Biology and applications of small nucleolar RNAs , 2011, Cellular and Molecular Life Sciences.

[32]  M. Esteller,et al.  DNA methylation-associated silencing of tumor-suppressor microRNAs in cancer , 2011, Oncogene.

[33]  A. Kibel,et al.  SnoRNA U50 is a candidate tumor-suppressor gene at 6q14.3 with a mutation associated with clinically significant prostate cancer. , 2007, Human molecular genetics.

[34]  S. Gerbi.  Small nucleolar RNA. , 1995, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[35]  Bert Vogelstein,et al.  DNMT1 and DNMT3b cooperate to silence genes in human cancer cells , 2002, Nature.

[36]  Hiroyuki Yamamoto,et al.  A genetic defect in exportin-5 traps precursor microRNAs in the nucleus of cancer cells. , 2010, Cancer cell.

[37]  Peter A. Jones,et al.  The Epigenomics of Cancer , 2007, Cell.

[38]  Tamás Kiss,et al.  Site-Specific Ribose Methylation of Preribosomal RNA: A Novel Function for Small Nucleolar RNAs , 1996, Cell.

[39]  A. Kibel,et al.  SnoRNA U 50 is a candidate tumor-suppressor gene at 6 q 14 . 3 with a mutation associated with clinically significant prostate cancer , 2008 .

[40]  M. Mourtada-Maarabouni,et al.  Growth arrest in human T-cells is controlled by the non-coding RNA growth-arrest-specific transcript 5 (GAS5) , 2010, Journal of Cell Science.

[41]  Tingting Li,et al.  Identification and characterization of human snoRNA core promoters. , 2010, Genomics.

[42]  T. Vulliamy,et al.  Mutations in the telomerase component NHP2 cause the premature ageing syndrome dyskeratosis congenita , 2008, Proceedings of the National Academy of Sciences.

[43]  Liang-Hu Qu,et al.  snoSeeker: an advanced computational package for screening of guide and orphan snoRNA genes in the human genome , 2006, Nucleic acids research.

[44]  J. Mattick.  Challenging the dogma: the hidden layer of non-protein-coding RNAs in complex organisms. , 2003, BioEssays : news and reviews in molecular, cellular and developmental biology.

[45]  Xiaojuan Du,et al.  1A6/DRIM, a Novel t-UTP, Activates RNA Polymerase I Transcription and Promotes Cell Proliferation , 2010, PloS one.

[46]  Daiya Takai,et al.  The CpG Island Searcher: A new WWW resource , 2003, Silico Biol..

[47]  International Human Genome Sequencing Consortium.  Finishing the euchromatic sequence of the human genome , 2004 .

[48]  M. McMahon,et al.  Ribosomal 18 S RNA Processing by the IGF-I-responsive WDR3 Protein Is Integrated with p53 Function in Cancer Cell Proliferation* , 2010, The Journal of Biological Chemistry.

[49]  Thomas D. Schmittgen,et al.  Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas. , 2007, Cancer cell.

[50]  Laurent Lestrade,et al.  snoRNA-LBME-db, a comprehensive database of human H/ACA and C/D box snoRNAs , 2005, Nucleic Acids Res..

[51]  M. Esteller,et al.  Validation of a DNA methylation microarray for 450,000 CpG sites in the human genome , 2011, Epigenetics.

[52]  Gretchen M. Williams,et al.  DICER1 Mutations in Familial Pleuropulmonary Blastoma , 2009, Science.

[53]  B. Horsthemke,et al.  Mechanisms of imprinting of the Prader–Willi/Angelman region , 2008, American journal of medical genetics. Part A.

[54]  D. Haussler,et al.  Ultraconserved Elements in the Human Genome , 2004, Science.

[55]  Laurie Smith,et al.  The RNA World of the Nucleolus: Two Major Families of Small RNAs Defined by Different Box Elements with Related Functions , 1996, Cell.

[56]  M. Esteller,et al.  CpG island hypermethylation-associated silencing of non-coding RNAs transcribed from ultraconserved regions in human cancer , 2010, Oncogene.

[57]  Manel Esteller,et al.  Dysregulation of microRNAs in cancer: Playing with fire , 2011, FEBS letters.